腹腔镜手术治疗黄色肉芽肿性胆囊炎的疗效分析  

Analysis of the Efficacy of Laparoscopic Surgery for Yellow Granulomatous Cholecystitis

作　　者：张家涛 王财庆 ZHANG Jiatao;WANG Caiqing(Department of Hepatobiliary and Pancreatic Surgery,Nanjing Gaochun People's Hospital,Nanjing,Jiangsu Province,211300 China)

机构地区：[1]南京市高淳人民医院肝胆胰外科,江苏南京211300

出　　处：《系统医学》2024年第11期120-122,126,共4页Systems Medicine

摘　　要：目的 探究腹腔镜手术治疗黄色肉芽肿性胆囊炎的效果。方法 选取2018年2月—2023年11月南京市高淳人民医院收治的80例黄色肉芽肿性胆囊炎患者作为研究对象,依据随机数表法分为对照组(n=40,行开腹手术)与观察组(n=40,行腹腔镜手术),比较两组的干预效果。结果 观察组治疗有效率(100.00%)高于对照组(77.50%),差异有统计学意义(χ^(2)=8.013,P=0.005)。观察组患者手术用时、术中出血量及住院时间、术后并发症发生率优于对照组,差异有统计学意义(P均<0.05)。结论 在临床上对黄色肉芽肿性胆囊炎患者应用腹腔镜手术治疗效果相对更突出,术中出血量更少,术后住院时间更短,可改善患者的预后,且并不明显增加并发症风险。Objective To investigate the effect of laparoscopic surgery in the treatment of yellow granulomatous chole-cystitis.Methods Eighty cases of yellow granulomatous cholecystitis patients admitted to Nanjing Gaochun People's Hospital from February 2018 to November 2023 were selected as the study subjects,and were divided into the control group(n=40,open abdominal surgery)and the observation group(n=40,laparoscopic surgery)based on the method of randomized number table,and the intervention effects of the two groups were compared.Results The treatment efficiency of the observation group(100.00%)was higher than that of the control group(77.50%),and the difference was statistically significant(χ^(2)=8.013,P=0.005).The operation time,intraoperative bleeding and hospitalization time,and postoperative complication rate of patients in the observation group were better than those in the control group,and the difference was statistically significant(all P<0.05).Conclusion In the clinical application of laparoscopic surgery for patients with yellow granulomatous cholecystitis,the effect of treatment is relatively more prominent,intraoperative bleeding is less,postoperative hospitalization time is shorter,which can improve the prognosis of patients,and does not significantly increase the risk of complications.

关 键 词：黄色肉芽肿性胆囊炎 腹腔镜手术 治疗有效率 并发症发生率 

分 类 号：R979[医药卫生—药品]